Vaccines
24 August 2021
BlueWillow Biologics Announces Positive Interim Results from Phase 1 Trial of Intranasal Anthrax Vaccine23 August 2021
Medigen Vaccine Biologics Announces Launch of Its COVID-19 Vaccine MVC-COV1901 Adjuvanted with Dynavax’s CpG 1018 Adjuvant23 August 2021
Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full U.S. FDA Approval for Individuals 16 Years and Older23 August 2021
Valneva Commences Rolling Submission to MHRA for its Inactivated, Adjuvanted COVID-19 Vaccine21 August 2021
Zydus receives EUA from DCGI for ZyCoV-D, the only needle-free COVID vaccine in the world19 August 2021
Soligenix Announces Positive Preclinical Data with Multiple Heat Stable Filovirus Vaccine Candidates17 August 2021
Pfizer and BioNTech Announce Submission of Initial Data to U.S. FDA to Support Booster Dose of COVID-19 Vaccine10 August 2021
YishengBio Announces PIKA recombinant COVID-19 vaccine received Phase I clinical trial IND clearance from New Zealand5 August 2021
Valneva Announces Positive Phase 3 Pivotal Results for its Single-Shot Chikungunya Vaccine CandidateNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports